HCA Healthcare, Inc. Files 10-Q for Period Ending March 31, 2024
Ticker: HCA · Form: 10-Q · Filed: May 2, 2024 · CIK: 860730
Sentiment: neutral
Topics: HCA Healthcare, 10-Q, Financial Report, Debt, Healthcare
TL;DR
<b>HCA Healthcare, Inc. has filed its Q1 2024 10-Q report, detailing financial positions and debt instruments.</b>
AI Summary
HCA Healthcare, Inc. (HCA) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. HCA Healthcare, Inc. filed a 10-Q report for the period ending March 31, 2024. The filing includes data related to various financial statement line items and debt instruments. Specific dates mentioned include 2024-03-31, 2023-12-31, and 2023-01-01. Key financial components such as Retained Earnings, Common Stock, and Noncontrolling Interest are detailed. Information pertains to different credit facilities and senior notes with various maturity dates.
Why It Matters
For investors and stakeholders tracking HCA Healthcare, Inc., this filing contains several important signals. This filing provides a snapshot of HCA Healthcare's financial health and debt obligations as of Q1 2024, crucial for investors assessing solvency and financial strategy. The detailed breakdown of credit facilities and senior notes offers insight into the company's capital structure and its ability to manage its debt load.
Risk Assessment
Risk Level: — HCA Healthcare, Inc. shows moderate risk based on this filing. The filing is a standard quarterly report (10-Q) which provides a detailed financial overview but does not contain significant new strategic information or performance indicators that would drastically alter risk perception.
Analyst Insight
Review the detailed debt maturity schedules and credit facility terms to understand HCA's liquidity and refinancing risk.
Key Numbers
- 2024-03-31 — Reporting Period End Date (10-Q filing)
- 2023-12-31 — Previous Year-End Date (Financial data reference)
- 2023-01-01 — Comparative Period Start Date (Financial data reference)
Key Players & Entities
- HCA Healthcare, Inc. (company) — Filer of the 10-Q report
- 2024-03-31 (date) — End of the reporting period
- 2023-12-31 (date) — Previous year-end reporting date
- 2023-01-01 (date) — Start of a comparative period
FAQ
When did HCA Healthcare, Inc. file this 10-Q?
HCA Healthcare, Inc. filed this Quarterly Report (10-Q) with the SEC on May 2, 2024.
What is a 10-Q filing?
A 10-Q is a quarterly financial report with unaudited financials, management discussion, and interim business updates. This particular 10-Q was filed by HCA Healthcare, Inc. (HCA).
Where can I read the original 10-Q filing from HCA Healthcare, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by HCA Healthcare, Inc..
What are the key takeaways from HCA Healthcare, Inc.'s 10-Q?
HCA Healthcare, Inc. filed this 10-Q on May 2, 2024. Key takeaways: HCA Healthcare, Inc. filed a 10-Q report for the period ending March 31, 2024.. The filing includes data related to various financial statement line items and debt instruments.. Specific dates mentioned include 2024-03-31, 2023-12-31, and 2023-01-01..
Is HCA Healthcare, Inc. a risky investment based on this filing?
Based on this 10-Q, HCA Healthcare, Inc. presents a moderate-risk profile. The filing is a standard quarterly report (10-Q) which provides a detailed financial overview but does not contain significant new strategic information or performance indicators that would drastically alter risk perception.
What should investors do after reading HCA Healthcare, Inc.'s 10-Q?
Review the detailed debt maturity schedules and credit facility terms to understand HCA's liquidity and refinancing risk. The overall sentiment from this filing is neutral.
How does HCA Healthcare, Inc. compare to its industry peers?
HCA Healthcare operates within the hospital and healthcare services industry, a sector characterized by regulatory oversight and significant capital investment.
Are there regulatory concerns for HCA Healthcare, Inc.?
The healthcare industry is subject to extensive regulation by government bodies such as CMS, impacting reimbursement rates and operational compliance.
Industry Context
HCA Healthcare operates within the hospital and healthcare services industry, a sector characterized by regulatory oversight and significant capital investment.
Regulatory Implications
The healthcare industry is subject to extensive regulation by government bodies such as CMS, impacting reimbursement rates and operational compliance.
What Investors Should Do
- Analyze the company's debt structure and maturity profile for the next 1-3 years.
- Examine any disclosed changes in credit facilities or debt covenants.
- Compare key financial metrics with industry benchmarks if available in the full filing.
Year-Over-Year Comparison
This is the initial filing analyzed for the specified period; no prior filing data is available for comparison within this context.
Filing Stats: 4,528 words · 18 min read · ~15 pages · Grade level 13.4 · Accepted 2024-05-02 16:30:35
Filing Documents
- hca-20240331.htm (10-Q) — 1798KB
- hca-ex22.htm (EX-22) — 2KB
- hca-ex31_1.htm (EX-31.1) — 13KB
- hca-ex31_2.htm (EX-31.2) — 14KB
- hca-ex32.htm (EX-32) — 13KB
- 0000950170-24-052195.txt ( ) — 6858KB
- hca-20240331.xsd (EX-101.SCH) — 896KB
- hca-20240331_htm.xml (XML) — 1151KB
Financial Statements (Unaudited)
Financial Statements (Unaudited): Condensed Consolidated Income Statements — for the quarters ended March 31, 2024 and 2023 3 Condensed Consolidated Comprehensive Income Statements — for the quarters ended March 31, 2024 and 2023 4 Condensed Consolidated Balance Sheets — March 31, 2024 and December 31, 2023 5 Condensed Consolidated Statements of Stockholders' Equity (Deficit) — for the quarters ended March 31, 2024 and 2023 6 Condensed Consolidated Statements of Cash Flows — for the quarters ended March 31, 2024 and 2023 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 27 Item 4.
Controls and Procedures
Controls and Procedures 27 Part II. Other Information Item 1.
Legal Proceedings
Legal Proceedings 27 Item 1A.
Risk Factors
Risk Factors 27 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 27 Item 5. Other Information 28 Item 6. Exhibits 29
Signatures
Signatures 30 2 HCA HEALTHCARE, INC. CONDENSED CONSOLIDATED INCOME STATEMENTS FOR THE QUARTERS ENDED MARCH 31, 2024 AND 2023 Unaudited (Dollars in millions, except per share amounts) 2024 2023 Revenues $ 17,339 $ 15,591 Salaries and benefits 7,707 7,084 Supplies 2,671 2,423 Other operating expenses 3,606 2,894 Equity in losses of affiliates 2 18 Depreciation and amortization 795 756 Interest expense 512 479 Losses (gains) on sales of facilities ( 201 ) 15 15,092 13,669 Income before income taxes 2,247 1,922 Provision for income taxes 445 379 Net income 1,802 1,543 Net income attributable to noncontrolling interests 211 180 Net income attributable to HCA Healthcare, Inc. $ 1,591 $ 1,363 Per share data: Basic earnings $ 6.01 $ 4.92 Diluted earnings $ 5.93 $ 4.85 Shares used in earnings per share calculations (in millions): Basic 264.435 276.910 Diluted 268.016 280.961 The accompanying notes are an integral part of the condensed consolidated financial statements. 3 HCA HEALTHCARE, INC. CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS FOR THE QUARTERS ENDED MARCH 31, 2024 AND 2023 Unaudited (Dollars in millions) 2024 2023 Net income $ 1,802 $ 1,543 Other comprehensive (loss) income before taxes: Foreign currency translation ( 8 ) 18 Unrealized (losses) gains on available-for-sale securities ( 2 ) 7 Other comprehensive (loss) income before taxes ( 10 ) 25 Income taxes (benefits) related to other comprehensive income items ( 2 ) 5 Other comprehensive (loss) income ( 8 ) 20 Comprehensive income 1,794 1,563 Comprehensive income attributable to noncontrolling interests 211 180 Comprehensive income attributable to HCA Healthcare, Inc. $ 1,583 $ 1,383 The accompanying notes are an integral part of the condensed consolidated financial s